首页> 外国专利> Complex microbial preparations for long-term control or prevention of opportunistic microbial infections

Complex microbial preparations for long-term control or prevention of opportunistic microbial infections

机译:复杂的微生物制剂,可长期控制或预防机会性微生物感染

摘要

The complex microbial formulation contains the components of the microscopic oomycete Psium origolandrum and the physiological microflora. The microscopic oomycete Psium origandrum and physiological microflora components are present in the composite formulation in a form that promotes their germination, subsequent growth from target tissues and colony formation. The microscopic oomycete pisium oliganlam is included in an amount of 103-107 CFU (colony forming units), preferably 104-105 CFU, per application cycle. The physiological microflora component comprises 5 × 10 5 to 5 × 10 10 CFU, preferably 5 × 10 7 to 5 × 10 9 per application cycle. The fermentation substrate found in Oomyces pisium origolandrum is a nutrient source for both microbial components. The complex microbial formulation contains at least one auxiliary substance from the group comprising desiccants, buffer system components, anti-caking substances and agents for creating a physiological osmotic environment. The physiological microbiota component is one of the components of the human microflora, one of the microorganisms of the green complex, such as the bacterium Capnositophaga sputigena, or one of the components of the healthy skin microflora, such as the bacterium Staphylococcus epidermidis, Or one of the components of a healthy vaginal microflora, such as peroxide-producing Lactobacillus crispatas. Either the microscopic oomycete pysium oliligand or the physiological microbiota component is present in the complex microbial formulation in the form of inactivated cells, cell extracts or isolated cell fractions. The microbial activator of Oomyces pycium origolandrum is yeast autolysate in an amount of 0.1 to 10% by weight of the total amount of the complex microbial preparation. Supplementary substances are adjusted so that they can be applied in the form of ointments, creams, oils or suppositories, or in the form of a liquid aqueous formulation.
机译:复杂的微生物制剂包含显微卵菌Psium origolandrum和生理菌群的成分。微观卵菌Psium origandrum和生理菌群组分以促进其萌发,随后从靶组织生长和菌落形成的形式存在于复合制剂中。在每个施用周期中,显微卵菌体低聚碘化磷的含量为103-107 CFU(菌落形成单位),优选为104-105 CFU。每个施用周期,生理菌群组分包含5×10 5至5×10 10 CFU,优选5×10 7至5×10 9 CFU。在Oomyces pisium origolandrum中发现的发酵底物是两种微生物成分的营养来源。复合微生物制剂包含选自干燥剂,缓冲系统组分,抗结块物质和用于产生生理渗透环境的试剂的至少一种辅助物质。生理微生物区系成分是人类微生物区系的一种成分,绿色复合物的一种微生物,例如Capnositophaga sputigena细菌,或者健康皮肤微生物区系的一种成分,例如表皮葡萄球菌,或者一种健康的阴道微生物区系的成分,例如产生过氧化物的薄脆乳杆菌。微观的卵菌性oom寡糖或生理菌群组分以灭活细胞,细胞提取物或分离的细胞级分的形式存在于复合微生物制剂中。酵母菌(Oomyces pycium origolandrum)的微生物活化剂是酵母自溶产物,其量为复合微生物制剂总量的0.1至10重量%。调整辅助物质,以便可以软膏,乳膏,油或栓剂形式使用,也可以以液体水性制剂形式使用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号